Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AKAN
AKAN logo

AKAN Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
31.700
Open
19.460
VWAP
25.35
Vol
12.42M
Mkt Cap
13.89M
Low
18.370
Amount
314.92M
EV/EBITDA(TTM)
--
Total Shares
534.42K
EV
7.28M
EV/OCF(TTM)
--
P/S(TTM)
--
Akanda Corp. is a United Kingdom-based company. The Company is a cannabis & hemp cultivation, manufacturing and distribution company. Its segments include Cultivation, Distribution & Corporate. The Cultivation segment is focused on the cultivation of medical cannabis and medical cannabis biomass. The Distribution segment undertakes the sale and distribution of medical cannabis products. The Corporate segment undertakes management and treasury services.
Show More

Events Timeline

(ET)
2026-04-29
12:10:00
Akanda Corp Trading Resumes
select
2026-04-29
12:00:00
Akanda Corp Trading Halted Due to Volatility
select
2026-04-28 (ET)
2026-04-28
09:50:00
Akanda Corp Trading Halted Due to Volatility
select
2026-04-10 (ET)
2026-04-10
20:00:00
Akanda Corp Trading Halted, News Pending
select
2026-01-26 (ET)
2026-01-26
17:30:00
Akanda Files to Sell 30.31M Common Shares
select
2026-01-09 (ET)
2026-01-09
19:50:00
Akanda Corp Trading Halted, News Pending
select
2024-09-05 (ET)
2024-09-05
11:01:43
Akanda files $1.5M common shares offering
select

News

stocktwits
4.5
04-24stocktwits
U.S. Stocks Rally with Tech Gains, Near All-Time Highs
  • Market Performance: The S&P 500 rose about 0.8% and the Nasdaq Composite increased by 1.63%, marking the fourth consecutive week of gains, driven by strong corporate earnings and policy support, reflecting robust investor confidence in tech stocks.
  • Cannabis Sector Surge: Akanda Corp. (AKAN) shares skyrocketed over 300% this week after the Trump administration advanced plans to reclassify marijuana as a Schedule III drug, with single-day gains reaching 214%, igniting a rally across the cannabis sector.
  • Strong Semiconductor Earnings: MaxLinear (MXL) shares surged more than 75% after reporting a 43% year-over-year revenue increase and raising guidance, highlighting robust demand for its optical and connectivity chips in AI data centers, showcasing the company's strong market position.
  • Psychedelic Drug Development: Enveric Biosciences (ENVB) shares jumped over 100% following Trump's executive order to accelerate research and approval for psychedelic therapies, marking the company's best week ever and reflecting optimistic market sentiment towards mental health drug development.
stocktwits
8.0
04-23stocktwits
DOJ Updates Marijuana Classification Policy
  • Policy Change Context: The U.S. Department of Justice has formally proposed reclassifying state-licensed medical marijuana from Schedule I to Schedule III, which, while not legalizing marijuana, reduces regulatory hurdles and offers tax relief for licensed operators, expected to enhance medical research and expand access to treatments.
  • Market Reaction: Following the announcement, shares of Tilray (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB), and IGC Pharma (IGC) fell between 2-5% in morning trading despite previous gains, indicating a cautious market response to the policy change.
  • Investor Sentiment: Retail sentiment on Stocktwits for TLRY, CGC, ACB, and IGC turned ‘extremely bullish’ with message volumes surging, reflecting optimistic expectations for the cannabis industry's revival, with some users claiming Tilray will become the “king of the U.S. cannabis market.”
  • Akanda Corp. Outperformance: In contrast to major cannabis stocks, Akanda Corp. (AKAN) saw a 6% increase, extending a remarkable 215% surge from the previous session, with investors debating whether this explosive rally is driven by optimism over cannabis reclassification or the stock's low float.
seekingalpha
8.5
04-09seekingalpha
Akanda Announces 1-for-4.5 Reverse Stock Split Effective April 2026
  • Reverse Stock Split Plan: Akanda announced a 1-for-4.5 reverse stock split effective April 13, 2026, aimed at increasing share price to attract more investors, which will reduce outstanding shares from approximately 2.4 million to about 534,400.
  • Shareholder Approval: The reverse stock split was approved by shareholders on November 28, 2025, and confirmed by the Board on March 23, 2026, demonstrating the company's commitment to optimizing its capital structure with shareholder backing.
  • Future Consolidation Possibility: The company indicated that it may undertake further consolidations based on a ratio selected by the Board, ranging from 2 pre-consolidation shares to 100, providing flexibility in capital management strategies.
  • Market Impact Expectations: The reverse stock split will take effect at market open, expected to improve the company's market performance; while it may have a short-term negative impact on stock price, it is anticipated to enhance the company's image and attractiveness in the long run.
seekingalpha
8.5
01-20seekingalpha
Akanda (AKAN) Signs $7M Private Placement Deal Expected to Close by January 21, 2026
  • Funding Initiative: Akanda is set to raise $7 million through a 12-month convertible promissory note private placement with institutional investors, aimed at bolstering marketing efforts, working capital, and general corporate needs, thereby enhancing financial flexibility.
  • Debt Repayment: The proceeds will be allocated towards debt repayment, which is expected to improve the company's capital structure, reduce financial risk, and enhance future financing capabilities.
  • Reverse Stock Split: Akanda has announced a 1-for-5 reverse stock split intended to increase the share price, attract more investor interest, and improve market liquidity.
  • Market Outlook: The transaction is expected to close by January 21, 2026, and if successfully executed, will provide the necessary funding support to help achieve the company's long-term strategic objectives.
Benzinga
4.5
2025-12-12Benzinga
Dow Gains More Than 100 Points as Lululemon Reports Strong Q3 Earnings
  • Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining 0.24% while the NASDAQ and S&P 500 fell by 0.34% and 0.13%, respectively.

  • Lululemon's Strong Earnings: Lululemon Athletica reported better-than-expected third-quarter earnings of $2.59 per share, surpassing estimates, and raised its full-year guidance.

  • Notable Stock Movements: cbdMD Inc shares surged 101% after compliance news, while Applied Therapeutics Inc saw a 48% drop following acquisition plans.

  • Global Market Trends: European and Asian markets closed higher, with the eurozone's STOXX 600 up 0.2% and Japan's Nikkei gaining 1.37%.

Benzinga
9.5
2025-12-05Benzinga
Ulta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Ulta Beauty Earnings Report: Ulta Beauty, Inc. reported third-quarter earnings of $5.14 per share, surpassing analyst expectations, and raised its full-year GAAP EPS guidance, leading to a 5.7% increase in share price during pre-market trading.

  • Other Notable Gainers: Several stocks saw significant pre-market gains, including Lion Group Holding Ltd (+57.3%), SMX (+42.9%), and Akanda Corp (+30.1%), following positive developments and shareholder approvals.

  • Stocks Experiencing Losses: Sportsman’s Warehouse Holdings Inc. faced an 18.8% drop after disappointing third-quarter results, while Protara Therapeutics Inc. fell 14.3% due to a public offering announcement.

  • Market Overview: The overall market showed mixed results, with some companies like Rubrik, Inc. and Zumiez Inc. reporting strong earnings and positive outlooks, while others like Hewlett Packard Enterprise Co. and Docusign Inc. reported weaker-than-expected results.

Valuation Metrics

The current forward P/E ratio for Akanda Corp (AKAN.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Akanda Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

today's gainers
Intellectia · 58 candidates
Volume: >= -100Price Change Pct: >= $5.00Relative Vol: >= 1.50Monthly Average Dollar Volume: >= -100
Ticker
Name
Market Cap$
top bottom
RDAC logo
RDAC
Rising Dragon Acquisition Corp
35.41M
AKAN logo
AKAN
Akanda Corp
9.35M
BRLS logo
BRLS
Borealis Foods Inc
24.25M
SAGT logo
SAGT
Sagtec Global Ltd
21.68M
SIMO logo
SIMO
Silicon Motion Technology Corp
5.07B
UBXG logo
UBXG
U-BX Technology Ltd
29.68M
list10 stocks up 5%
Intellectia · 371 candidates
Price Change Pct: >= $5.00
Ticker
Name
Market Cap$
top bottom
AGPU logo
AGPU
Axe Compute Inc
25.59M
ELPW logo
ELPW
eLong Power Holding Ltd
2.23M
TORO logo
TORO
Toro Corp
112.81M
NMAX logo
NMAX
Newsmax Inc
940.13M
BEEM logo
BEEM
Beam Global
32.13M
XNDU logo
XNDU
Xanadu Quantum Technologies Ltd
8.18B
low float high volume medical stock
Intellectia · 22 candidates
Sector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchVolume: >= 1,000,000List Exchange: XNYS, XNAS, XASEFloating Shares: <= 30,000,000
Ticker
Name
Market Cap$
top bottom
AKAN logo
AKAN
Akanda Corp
1.66M
IBIO logo
IBIO
iBio Inc
60.11M
BIAF logo
BIAF
bioAffinity Technologies Inc
21.32M
AZTR logo
AZTR
Azitra Inc
3.82M
KPTI logo
KPTI
Karyopharm Therapeutics Inc
109.27M
SNGX logo
SNGX
Soligenix Inc
12.20M
stocks under $2 that fell 5% or more
Intellectia · 109 candidates
Price: <= $2.00Price Change Pct: <= $-5.00
Ticker
Name
Market Cap$
top bottom
PBM logo
PBM
Psyence Biomedical Ltd
890.11K
IOBT logo
IOBT
IO Biotech Inc
14.94M
VERO logo
VERO
Venus Concept Inc
3.51M
IBG logo
IBG
Innovation Beverage Group Ltd
3.33M
JFBR logo
JFBR
Jeffs Brands Ltd
2.33M
SURG logo
SURG
Surgepays Inc
25.72M
find stocks under $2 that fell 5% or more
Intellectia · 109 candidates
Price: <= $2.00Price Change Pct: <= $-5.00
Ticker
Name
Market Cap$
top bottom
PBM logo
PBM
Psyence Biomedical Ltd
890.11K
IOBT logo
IOBT
IO Biotech Inc
14.94M
VERO logo
VERO
Venus Concept Inc
3.51M
IBG logo
IBG
Innovation Beverage Group Ltd
3.33M
JFBR logo
JFBR
Jeffs Brands Ltd
2.33M
SURG logo
SURG
Surgepays Inc
25.72M
Good cheap stock to buy
Intellectia · 746 candidates
Market Cap: <= 2.00BPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: <= 15
Ticker
Name
Market Cap$
top bottom
NIVF logo
NIVF
NewGenIvf Group Ltd
553.20K
LGHL logo
LGHL
Lion Group Holding Ltd
755.53K
ICON logo
ICON
Icon Energy Corp
1.57M
TRNR logo
TRNR
Interactive Strength Inc
1.70M
BOXL logo
BOXL
Boxlight Corp
1.73M
DRCT logo
DRCT
Direct Digital Holdings Inc
1.74M
stocks that fell over 20% yesterday
Intellectia · 19 candidates
Price Change Pct: $-100.00 - $-20.00
Ticker
Name
Market Cap$
top bottom
PBM logo
PBM
Psyence Biomedical Ltd
890.11K
IOBT logo
IOBT
IO Biotech Inc
14.94M
VERO logo
VERO
Venus Concept Inc
3.51M
IBG logo
IBG
Innovation Beverage Group Ltd
3.33M
JFBR logo
JFBR
Jeffs Brands Ltd
2.33M
SURG logo
SURG
Surgepays Inc
25.72M

Whales Holding AKAN

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Akanda Corp (AKAN) stock price today?

The current price of AKAN is 25.99 USD — it has increased 48.6

What is Akanda Corp (AKAN)'s business?

Akanda Corp. is a United Kingdom-based company. The Company is a cannabis & hemp cultivation, manufacturing and distribution company. Its segments include Cultivation, Distribution & Corporate. The Cultivation segment is focused on the cultivation of medical cannabis and medical cannabis biomass. The Distribution segment undertakes the sale and distribution of medical cannabis products. The Corporate segment undertakes management and treasury services.

What is the price predicton of AKAN Stock?

Wall Street analysts forecast AKAN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AKAN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Akanda Corp (AKAN)'s revenue for the last quarter?

Akanda Corp revenue for the last quarter amounts to 41.43K USD, decreased

What is Akanda Corp (AKAN)'s earnings per share (EPS) for the last quarter?

Akanda Corp. EPS for the last quarter amounts to -20330.44 USD, decreased

How many employees does Akanda Corp (AKAN). have?

Akanda Corp (AKAN) has 46 emplpoyees as of April 30 2026.

What is Akanda Corp (AKAN) market cap?

Today AKAN has the market capitalization of 13.89M USD.